Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
  Mahamaya Lifesciences Ltd
Registered Office: #DPT-033 Gr Flr Plt #79-80 DLF,Prime Tower F Blo.Okhla Phase1 , New Delhi - 110020 , New Delhi , India.
Phone : +91-11 4656 1474   Fax:
Email :  cs@mahamayalifesciences.com  
Website :  https://www.mahamayalifesciences.com/
Initial public offer of up to 61,78,800 equity shares of face value of 10/- each ("equity shares") of Mahamaya Lifesciences Limited ("MLL" or the "company") for cash at price of 114/- per equity share (including a share premium of 104/- per equity share) (the "offer price"), aggregating up to 70.44 crores ("the offer"), comprising a fresh offer of upto 56,38,800 equity shares aggregating to 64.28 crores (the "fresh offer") and an offer for sale of upto 5,40,000 equity shares (the "offered shares") of face value of 10/- each aggregating up to 6.16 crores ("offer for sale") comprising of 3,70,000 equity shares aggregating up to 4.22 crores by Krishnamurthy Ganesan and 1,70,000 equity shares aggregating up to 1.94 crores by Lalitha Krishnamurthy (collectively referred to as the "selling shareholders") out of which 3,09,600 equity shares of face value of 10/- each, at an offer price of 114/- per equity share for cash, aggregating up to 3.53 crores will be reserved for subscription by the market maker to the offer ( the "market maker reservation portion"). The offer less market maker reservation portion i.e. net offer of 58,69,200 equity shares of face value of 10/- each, at an offer price of 114/- per equity share for cash, aggregating up to 66.91 crores is hereinafter referred to as the "net offer". The offer and net offer will constitute 26.40% and 25.08% respectively of the post-offer paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.

Issue Money Payable On
Opens On Closes On Application Allotment
11-Nov-25 13-Nov-25 Rs114.00-0.00 Rs0.00-0.00
Minimum Application for shares in Nos :2400  Further Multiples of :1200

  RsCr Lead Managers to the Issue
Project Cost 61.96
Oneview Corporate Advisors Pvt Ltd
Project Financed through Current Offer 70.44  
Post Issue Equity Share Capital 23.41  
Issue Price Rs114.00  
 
Projects
 Purchase of equipment for existing formulation plant Funding working capital requirement of the company
 Funding capital expenditure towards setting up of a new technical manufacturing plant General corporate purposes
 Construction of warehouse building and purchase of machinery
Promoted By
 Krishnamurthy Ganesan
 Lalitha Krishnamurthy
 Prashant Krishnamurthy
Listing At
 BSE - SME 
Registrar to the Issue
 KFin Techologies Ltd